Pharmaceutical companies deserve scrutiny—but how far do the documented problems go? This video examines industry influence, regulation, doctor conflicts, and how to judge health claims without abandoning evidence.
From supplements and prescription drugs to exercise, sleep and social connection, this video examines which popular longevity strategies have meaningful human evidence—and which remain interesting but unproven.
NAD boosters are widely marketed for energy and longevity. But new human research raises an important question: does changing an NAD marker translate into meaningful health benefits?
Wealth can buy exceptional healthcare and early access to research, but does it buy a proven way to slow human ageing? Dr Deepa examines the evidence behind the headlines.
Several biotechnology companies are now testing ambitious anti-aging approaches. But entering human trials is not the same as reversing aging. Here is what to look for when judging the evidence.
A new human trial has begun testing genetic instructions intended to make older cells behave more like younger ones. But what was injected, what is being tested, and what has not yet been shown?
Off-label prescribing is common, but it deserves careful questions after 60. Learn why a medicine’s approved label is only part of the story—and what makes prescribing safer.
Magnesium matters, but increasing a supplement dose after 60 is not always straightforward. Kidney function, medicines, blood pressure, total intake and symptoms can all change the picture.
A standard cholesterol panel is valuable, but it may not include Lp(a), an inherited risk marker that can add important context to your heart-health picture.
After 60, everyday challenges such as stairs, poor sleep or a minor illness can sometimes have a bigger effect. Learn why shrinking reserves may matter more than any single test result.
